High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
Jun Sik YoonJi Hoon HongSoo-Young ParkSeung-Up KimHwi Young KimJu Yeon KimMoon Haeng HurMin Kyung ParkYun Bin LeeHan-Ah LeeGi Ae KimDong Hyun SinnSung Jae ParkYoun Jae LeeYun Joon KimJung Hwan YoonJeong-Hoon LeePublished in: Alimentary pharmacology & therapeutics (2024)
The use of high-dose PPI was independently associated with increased risks of mortality and cirrhotic complications.
Keyphrases